FDA inspection
Pacira Pharmaceuticals, Inc.: FDA inspection ending Mar 25, 2026
FDA inspection 1316070 · Voluntary Action Indicated (VAI) · San Diego, CA
Key facts
| Inspection ID | 1316070 |
|---|---|
| Firm | Pacira Pharmaceuticals, Inc. |
| FEI number | 3002783962 |
| Address | 10450 Science Center Dr |
| City | San Diego |
| State | CA |
| ZIP | 92121 |
| Country | United States |
| Fiscal year | 2026 |
| Inspection end date | Mar 25, 2026 |
| Classification | Voluntary Action Indicated (VAI) |
| Project area | Drug Quality Assurance |
| Product type | Drugs |
At a glance
- None Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 10–99 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data